These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10358815)

  • 1. Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis.
    Shetty AK; Zganjar BE; Ellis GS; Ludwig IH; Gedalia A
    J Pediatr Ophthalmol Strabismus; 1999; 36(3):125-8. PubMed ID: 10358815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate treatment for sarcoid-associated panuveitis.
    Dev S; McCallum RM; Jaffe GJ
    Ophthalmology; 1999 Jan; 106(1):111-8. PubMed ID: 9917790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate therapy in systemic-onset juvenile rheumatoid arthritis in Saudi Arabia: a retrospective analysis.
    al-Sewairy W; al-Mazyed A; al-Dalaan ; al-Balaa S; Bahabri S
    Clin Rheumatol; 1998; 17(1):52-7. PubMed ID: 9586680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders.
    Singsen BH; Goldbach-Mansky R
    Rheum Dis Clin North Am; 1997 Nov; 23(4):811-40. PubMed ID: 9361157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis.
    Lin YT; Tsai MJ; Wang LH; Huang MT; Yang YH; Chiang BL
    J Formos Med Assoc; 2000 Aug; 99(8):623-9. PubMed ID: 10969505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group.
    Ravelli A; Gerloni V; Corona F; Falcini F; Lepore L; De Sanctis R; Zulian F; Buoncompagni A; Sardella ML; Strano CG; Alessio M; Fantini F; Bardare M; Martini A
    Clin Exp Rheumatol; 1998; 16(2):181-3. PubMed ID: 9536397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
    Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
    Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis.
    Reiff A; Shaham B; Wood BP; Bernstein BH; Stanley P; Szer IS
    Clin Exp Rheumatol; 1995; 13(1):113-8. PubMed ID: 7774090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose methotrexate in systemic onset juvenile chronic arthritis.
    Speckmaier M; Findeisen J; Woo P; Hall A; Sills JA; Price T; Hollingworth P; Craft A; Ansell BM
    Clin Exp Rheumatol; 1989; 7(6):647-50. PubMed ID: 2612084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept in systemic juvenile idiopathic arthritis.
    Russo RA; Katsicas MM; Zelazko M
    Clin Exp Rheumatol; 2002; 20(5):723-6. PubMed ID: 12412209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis.
    Rose CD; Singsen BH; Eichenfield AH; Goldsmith DP; Athreya BH
    J Pediatr; 1990 Oct; 117(4):653-9. PubMed ID: 2213397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
    Hissink Muller PC; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Brederije IC; Bekkering WP; Kuijpers TW; van Rossum MA; van Suijlekom-Smit LW; van den Berg JM; Allaart CF; Ten Cate R
    Pediatr Rheumatol Online J; 2017 Feb; 15(1):11. PubMed ID: 28166785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis.
    Tuková J; Chládek J; Nemcová D; Chládková J; Dolezalová P
    Clin Exp Rheumatol; 2009; 27(6):1047-53. PubMed ID: 20149329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
    Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
    Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.
    Lahdenne P; Rapola J; Ylijoki H; Haapasaari J
    J Rheumatol; 2002 Nov; 29(11):2442-5. PubMed ID: 12415606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
    Chang CY; Meyer RM; Reiff AO
    Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis.
    Wallace CA; Bleyer WA; Sherry DD; Salmonson KL; Wedgwood RJ
    Arthritis Rheum; 1989 Jun; 32(6):677-81. PubMed ID: 2735961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.